Our Alzheimer’s disease platform includes the transgenic CVN and Tg2576 mouse models, which display pathologies associated with Alzheimer’s disease. Aged rodents and scopolamine-induced amnesia models are also available. The models are accompanied by cognitive testing, magnetic resonance imaging (MRI), measurement of the levels of soluble and insoluble beta amyloid, immunohistochemical measurements and relevant biomarkers, providing an extensive platform for pharmaceutical research and development. We've answered some frequently asked questions about our Alzheimer's disease models.

Schedule model validation discussion